Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CLDX | BMY | AMGN | GSK | GILD |
Company | Celldex Therapeutics | Bristol-Myers Squibb Company | Amgen Inc | Gsk Plc ADR | Gilead Sciences Inc |
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
Open | 36.29 | 47.39 | 273.45 | 41.06 | 67.47 |
High | 37.15 | 47.50 | 274.35 | 41.11 | 67.90 |
Low | 35.86 | 44.37 | 267.24 | 40.81 | 65.09 |
Last | 36.26 | 44.70 | 269.38 | 40.91 | 65.27 |
Change | -0.76 | -4.16 | -3.63 | +0.05 | -1.81 |
% Change | -2.05% | -8.51% | -1.33% | +0.12% | -2.70% |
Volume | 1,021,700 | 45,058,809 | 1,792,600 | 3,461,976 | 15,162,300 |
20-Day Average Volume | 640,050 | 12,857,450 | 2,149,520 | 2,997,370 | 6,861,275 |
Previous Close | 37.02 | 48.86 | 273.01 | 40.86 | 67.08 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 39.38 | 49.94 | 270.70 | 40.86 | 68.68 |
20-Day Raw Stochastic | 6.21% | 3.27% | 31.20% | 43.17% | 2.05% |
20-Day Relative Strength | 39.14% | 28.31% | 44.80% | 48.20% | 28.32% |
Weighted Alpha | -4.17 | -34.75 | +9.12 | +15.48 | -23.73 |
Today's Opinion | 8% Buy | 88% Sell | 72% Sell | 56% Buy | 100% Sell |
Previous Opinion | 24% Buy | 88% Sell | 40% Sell | 40% Buy | 100% Sell |
Last Month's Opinion | 64% Buy | 8% Sell | 24% Buy | 100% Buy | 88% Sell |
Performance | |||||
5-Days | |||||
%Chg | -5.89% since 04/18/24 | -7.45% since 04/18/24 | +2.52% since 04/18/24 | +4.18% since 04/18/24 | -1.35% since 04/18/24 |
Low | 35.86 on 04/25/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 39.37 on 04/19/24 | 65.09 on 04/25/24 |
High | 39.67 on 04/23/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 41.26 on 04/23/24 | 67.90 on 04/25/24 |
1-Month | |||||
%Chg | -12.50% since 03/25/24 | -14.45% since 03/25/24 | -4.07% since 03/25/24 | -4.48% since 03/25/24 | -10.07% since 03/25/24 |
Low | 35.86 on 04/25/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 39.15 on 04/18/24 | 65.09 on 04/25/24 |
High | 42.38 on 03/27/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 43.22 on 03/28/24 | 73.87 on 03/28/24 |
3-Month | |||||
%Chg | -2.89% since 01/25/24 | -9.90% since 01/25/24 | -13.18% since 01/25/24 | +5.33% since 01/25/24 | -18.65% since 01/25/24 |
Low | 34.65 on 02/02/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 38.86 on 01/29/24 | 65.09 on 04/25/24 |
High | 53.18 on 03/04/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 43.84 on 03/07/24 | 80.51 on 01/26/24 |
6-Month | |||||
%Chg | +54.30% since 10/25/23 | -21.04% since 10/25/23 | -1.02% since 10/25/23 | +13.48% since 10/25/23 | -16.74% since 10/25/23 |
Low | 22.11 on 10/30/23 | 44.37 on 04/25/24 | 249.70 on 10/31/23 | 33.67 on 11/02/23 | 65.09 on 04/25/24 |
High | 53.18 on 03/04/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 43.84 on 03/07/24 | 87.86 on 01/19/24 |
Key Statistics | |||||
Market Capitalization, $K | 2,069,455 | 99,027,448 | 146,436,016 | 84,679,904 | 83,519,768 |
Shares Outstanding, K | 55,901 | 2,026,759 | 536,376 | 2,072,440 | 1,245,077 |
Annual Sales | 6,880,000 | 45,006,000,000 | 28,190,000,000 | 37,725,000,000 | 27,116,000,000 |
Annual Net Income | -141,430,000 | 8,025,000,000 | 6,717,000,000 | 6,129,940,000 | 5,665,000,000 |
Last Quarter Sales | 4,130,000 | 11,477,000,000 | 8,196,000,000 | 9,980,060,000 | 7,114,000,000 |
Last Quarter Net Income | -43,310,000 | 1,762,000,000 | 767,000,000 | 433,200,000 | 1,429,000,000 |
60-Month Beta | 1.49 | 0.39 | 0.58 | 0.64 | 0.19 |
Per-Share Information | |||||
Most Recent Earnings | -0.57 on 02/26/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 0.72 on 01/31/24 | 1.72 on 02/06/24 |
Latest Earnings Date | 05/02/24 | 04/25/24 | 05/02/24 | 05/01/24 | 04/25/24 |
Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.397 on 02/22/24 | 0.770 on 03/14/24 |
Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 02/22/24 | 03/14/24 |
Ratios | |||||
Price/Earnings ttm | 0.00 | 6.53 | 14.67 | 10.71 | 9.97 |